title: Radioimmunotherapy: From Current Clinical Success to Future Industrial Breakthrough?
authors.affiliation: University Hospital-ICO-CRCNA, Inserm U892, CNRS UMR 6299, Nantes-Saint-Herblain, France.
authors.forename: Françoise
authors.initials: F
authors.lastname: Kraeber-Bodéré
authors.affiliation: Groupement d'Intérêt Public Arronax, University of Nantes, Nantes, France; and.
authors.forename: Jacques
authors.initials: J
authors.lastname: Barbet
authors.affiliation: Groupement d'Intérêt Public Arronax, University of Nantes, Nantes, France chatal@arronax-nantes.fr.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Chatal
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000628:therapy*; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D016499:Radioimmunotherapy / Q000379:methods*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D066246:ErbB Receptors; D018796:Immunoconjugates; D019275:Radiopharmaceuticals; D018719:Erb-b2 Receptor Tyrosine Kinases